Inflammation and Alzheimer’s disease
Authors:
- 30 October 2010
- journal article
- review article
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 33 (10) , 1539-1556
Abstract
Alzheimer’s disease (AD) is the most common form of dementia. It is characterized by extracellular deposition of a specific protein, beta-amyloid peptide fibrils, and is accompanied by extensive loss of neurons in the brains of affected individuals. Although the pathophysiologic mechanism is not fully established, inflammation appears to be involved. Neuroinflammation has been known to play a critical role in the pathogenesis of chronic neurodegenerative disease in general, and in AD in particular. Numerous studies show the presence of a number of markers of inflammation in the AD brain: elevated inflammatory cytokines and chemokines, and accumulation of activated microglia in the damaged regions. Epidemiological studies have shown that long-term use of non-steroidal anti-inflammatory drugs suppresses the progression of AD and delays its onset, suggesting that there is a close correlation between neuroinflammation and AD pathogenesis. The aim of this review is (1) to assess the association between neuroinflammation and AD through discussion of a variety of experimental and clinical studies on AD and (2) to review treatment strategies designed to treat or prevent AD.Keywords
This publication has 193 references indexed in Scilit:
- Pronounced microgliosis and neurodegeneration in aged rats after tau gene transferNeurobiology of Aging, 2010
- Transcriptome analysis of a tau overexpression model in rats implicates an early pro-inflammatory responseExperimental Neurology, 2010
- Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little?Neuron, 2009
- Mechanisms of tau-induced neurodegenerationActa Neuropathologica, 2009
- Neuronal Chemokines: Versatile Messengers In Central Nervous System Cell InteractionMolecular Neurobiology, 2007
- Causes of oxidative stress in Alzheimer diseaseCellular and Molecular Life Sciences, 2007
- NEUROPROTECTIVE EFFECTS OF CURCUMIN2007
- ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD StudyArchives of Neurology, 2006
- Alzheimer's diseaseThe Lancet, 2006
- Neuroinflammation in Alzheimer's disease and prion diseaseGlia, 2002